Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor XIII (FXIII), also known as fibrin stabilizing factor, is a plasma protein and the final enzyme in the blood coagulation cascade. It plays a critical role in stabilizing blood clots by crosslinking fibrin molecules, thereby increasing clot strength and resistance to premature breakdown (fibrinolysis). Deficiency of factor XIII leads to a rare bleeding disorder characterized by poor clot stability. Treatment involves replacement therapy with purified or recombinant FXIII concentrates.
Replacement therapy with purified or recombinant FXIII concentrates
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor XIII (FXIII).